Canker Sores and Behçet's Disease — When Oral Ulcers Are a Red Flag

TL;DR

Behçet's disease is a systemic vasculitis in which recurrent oral ulcers are the only mandatory diagnostic criterion — they're present in nearly 98% of patients and are usually the first symptom. The oral ulcers in Behçet's look identical to ordinary aphthous ulcers (canker sores). You cannot distinguish Behçet's from standard RAS based on the mouth alone. The distinguishing features are systemic: genital ulcers (70–80% of patients), eye inflammation — particularly uveitis (50–70%), skin lesions (erythema nodosum, pseudofolliculitis), and in severe cases, vascular or neurological involvement. If you have recurrent oral ulcers plus any of these features, Behçet's warrants investigation. Diagnosis is clinical — there is no definitive blood test — and requires a rheumatologist. Treatment is entirely different from ordinary canker sore management.

What Is Behçet's Disease?

Behçet's disease (also called Behçet's syndrome) is a systemic inflammatory disorder of unknown cause, classified among the vasculitides — conditions characterized by inflammation of blood vessels. It follows a relapsing-remitting course: periods of active disease with flares of symptoms, followed by remissions.

The disease was described by Turkish dermatologist Hulusi Behçet in 1937, who identified the triad of oral ulcers, genital ulcers, and eye inflammation as a distinct syndrome. Prevalence is highest along the historical Silk Road — Turkey, Iran, Japan, China, and the Middle East — with much lower prevalence in Northern Europe and North America. This geographic distribution suggests a genetic-environmental interaction.

It is not an autoimmune disease in the conventional sense (no specific autoantibody is required for diagnosis) — it is better classified as an autoinflammatory disorder driven by neutrophil hyperactivity and vascular inflammation.

The Oral Ulcers: Identical to Canker Sores

This is the central clinical problem: the oral ulcers of Behçet's disease are morphologically indistinguishable from ordinary recurrent aphthous stomatitis.

They present as:

• Round or oval shallow ulcers with a central yellow-white pseudomembrane
• Erythematous (red) halo around the ulcer
• Painful, typically lasting 1–2 weeks
• Recurrent, often multiple
• Located on the non-keratinized mucosa (inner cheeks, lips, soft palate, tongue) — same sites as RAS

The only features that may suggest Behçet's rather than RAS based on oral ulcers alone are frequency (Behçet's patients typically have very frequent, often continuous outbreaks) and severity (deeper, more numerous, or major-type ulcers). But these are tendencies, not diagnostic.

You cannot diagnose or exclude Behçet's based on the oral ulcers alone. The diagnosis requires systemic features.

Diagnostic Criteria: What Makes It Behçet's

The International Study Group criteria (1990, revised 2014 International Criteria for Behçet's Disease — ICBD) define the diagnosis. The 1990 criteria require recurrent oral ulcers (3× per year minimum) plus at least 2 of the following:

The ICBD scoring system also includes vascular lesions and neurological involvement. A score of ≥4 points is diagnostic.

Genital Ulcers

The most specific feature distinguishing Behçet's from ordinary RAS. In women: ulcers on the vulva or vagina, often painful and leaving scars (unlike most RAS). In men: ulcers on the scrotum (scarring ulcers on the scrotum are highly specific for Behçet's). Genital ulcers may not always be volunteered — clinicians need to ask specifically.

Eye Involvement (Uveitis)

Ocular Behçet's is the most feared manifestation. Posterior uveitis and retinal vasculitis can progress to blindness within years without treatment. Eye symptoms may be subtle early: floaters, blurred vision, eye redness. Any oral-ulcer patient with eye symptoms warrants urgent ophthalmological referral.

Skin Lesions

• Erythema nodosum: Tender red nodules, typically on the lower legs
• Pseudofolliculitis: Acne-like pustular lesions not associated with hair follicles
• Superficial thrombophlebitis: Red, tender cords along superficial veins

Pathergy

A positive pathergy test: a sterile skin prick produces a pustule or papule at the site within 24–48 hours. This represents neutrophil hyperreactivity. The test is more sensitive in patients from high-prevalence regions (Turkey, Japan) than in Western populations.

When to Suspect Behçet's

Consider Behçet's evaluation when:

1. Oral ulcers + genital ulcers — This combination is highly specific; investigate urgently
2. Oral ulcers + eye symptoms — Floaters, visual changes, or uveitis alongside RAS
3. Oral ulcers occurring ≥3× per year + any skin lesion consistent with erythema nodosum or pseudofolliculitis
4. Very frequent, severe oral ulcers that don't respond to any standard intervention — particularly if major-type (>10mm) or herpetiform clusters
5. Family history of Behçet's — there is genetic clustering
6. Geographic ancestry from high-prevalence regions (Turkey, Iran, Japan, Middle East, Silk Road corridor)

What Behçet's Is Not

It is not herpes. Behçet's oral ulcers culture negative for HSV. They don't have the prodromal vesicle stage, don't occur on keratinized tissue (gum, hard palate), and don't respond to antivirals.

It is not ordinary canker sores that are "just bad." Frequency and severity alone don't distinguish them — the systemic features do.

It is not Crohn's disease, though IBD can cause oral and genital ulcers. Crohn's-related oral ulcers often have distinct morphology (linear sulcus ulcers, cobblestoning); the GI symptoms are usually dominant.

It is not reactive arthritis (Reiter's syndrome), which also involves oral ulcers and genital ulcers, but typically has the additional features of arthritis and urethritis.

Diagnosis and Who to See

Behçet's is a clinical diagnosis — there is no definitive blood test or biopsy finding. Labs in active disease may show elevated inflammatory markers (ESR, CRP, WBC), and HLA-B51 is associated with higher risk in some populations, but these are neither sensitive nor specific enough to confirm or exclude.

Referral: A rheumatologist is the appropriate specialist for Behçet's evaluation and management. Ophthalmologist involvement is essential if any eye symptoms are present.

Treatment: Completely Different From Ordinary RAS

Treatment of Behçet's disease is systemic and managed by a rheumatologist. The disease-level management is categorically different from ordinary canker sore management — but individual ulcer pain and healing can still be addressed with the same tools that work for ordinary canker sores.

Managing individual oral ulcers (same tools as RAS):

The oral ulcers in Behçet's respond to the same local treatments as ordinary aphthous ulcers, because the lesion itself is the same regardless of the underlying cause:

• Debacterol — chemical cauterization that provides near-complete pain relief within minutes and cuts healing time roughly in half. Works on the ulcer surface regardless of what produced it. Requires a dentist visit.
• Topical corticosteroid gel (triamcinolone in Orabase, fluocinonide) — suppresses local inflammation at the ulcer site; reduces healing time
• Physical barrier patch — seals the ulcer for 8–12 hours, blocking food and saliva contact. Practical between-meal management.
• Benzocaine 20% gel — fast topical anesthetic for acute pain

For the full ranking of individual ulcer treatments by evidence, see The Fastest Way to Heal a Canker Sore.

For disease-level management of Behçet's (rheumatologist-managed):

• Colchicine — first-line for mucocutaneous disease; reduces frequency and severity of oral/genital ulcers (Yurdakul et al., 2001 — PMID: 11467722)
• Apremilast (Otezla) — FDA-approved specifically for Behçet's oral ulcers; PDE4 inhibitor
• Prednisolone — for acute flares
• Azathioprine — for mucocutaneous and eye disease
• Anti-TNF biologics (infliximab, adalimumab) — for refractory disease, severe eye involvement, and neurological manifestations
• Interferon-α — used for eye disease in some regions

What not to do: Treating Behçet's as ordinary RAS with nutritional supplementation alone misses the disease. Managing individual ulcers with Debacterol or patches is appropriate, but it doesn't address the underlying vasculitic process. Uncontrolled ocular Behçet's leads to blindness — delayed systemic diagnosis has consequences.